Table 2.
Summary of previous cases associated with gastrointestinal bleeding and prostate cancer.
| Age | Case symptoms | Medical history | Main diagnosis | Gleason score | Treatment | Prognosis | Reference |
|---|---|---|---|---|---|---|---|
| 61 | Lower gastrointestinal bleeding, rectal pain, and psoriasiform dermatitis | BPH; hypertension | Metastatic prostate cancer (bone metastasis) | 8 | ADT, radiotherapy, and chemotherapy | Clinical improvement, including decreased rectal bleeding, resolution of skin lesions, and no adverse effects | (10) |
| 76 | Upper gastrointestinal bleeding and melena | Metastatic prostate cancer (bone metastasis) | ·Metastatic prostate cancer (bone metastasis); ·Secondary duodenal carcinoma |
Unknown | Unknown | Death occurred after 1 month due to septic shock | (11) |
| 77 | Epistaxis, hemoptysis, hematuria, hematemesis, and hemorrhagic shock | Unknown | ·Metastatic prostate cancer (bone metastasis); ·Cancer-related DIC |
7 | ·ADT, abiraterone acetate; ·Anticoagulation, platelet replacement, coagulation factors, and fibrinogen |
Death occurred after 6 months | (12) |
| 81 | Altered mental status, aphasia, and left-sided hemiparesis, coffee ground emesis | Prostate cancer; hypertension | ·Metastatic prostate cancer (bone metastasis); ·Gastric metastasis |
Unknown | ADT, endoscopic hemostasis treatment | Death occurred after his family decided to withdraw care | (13) |
BPH, Benign prostatic hyperplasia; ADT, Androgen deprivation therapy; DIC, Disseminated intravascular coagulation.